IVBT (Innovation1 Biotech) Long-Term Debt: $0.56 Mil (As of Feb. 2024)


IVBT Innovation1 Biotech Inc IVBT
12 GF Score
Price $0.00
View Full Analysis

What is Innovation1 Biotech Long-Term Debt?

Innovation1 Biotech IVBT 12 Long-Term Debt is $0.56 Mil as of Feb. 2024. GuruFocus rates IVBT with a GF Score™ of 12/100.

Innovation1 Biotech's Long-Term Debt for the quarter that ended in Feb. 2024 was $0.56 Mil.

Innovation1 Biotech's quarterly Long-Term Debt increased from Aug. 2023 ($0.22 Mil) to Nov. 2023 ($0.42 Mil) and increased from Nov. 2023 ($0.42 Mil) to Feb. 2024 ($0.56 Mil).

Innovation1 Biotech's annual Long-Term Debt stayed the same from Aug. 2021 ($0.00 Mil) to Aug. 2022 ($0.00 Mil) but then increased from Aug. 2022 ($0.00 Mil) to Aug. 2023 ($0.22 Mil).

Innovation1 Biotech  (OTCPK:IVBT) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Innovation1 Biotech Long-Term Debt Related Terms

Innovation1 Biotech Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Innovation1 Biotech's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovation1 Biotech Long-Term Debt Chart

Innovation1 Biotech Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.22

Innovation1 Biotech Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.11 0.22 0.42 0.56
IVBT
12GF Score
Innovation1 Biotech Inc IVBT
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $0.56 Mil mean?
Innovation1 Biotech (IVBT) has a Long-Term Debt of $0.56 Mil as of Feb. 2024.
Is Innovation1 Biotech's Long-Term Debt too high?
Innovation1 Biotech's current Long-Term Debt is $0.56 Mil. Overall, Innovation1 Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Innovation1 Biotech's Long-Term Debt compare to NVIV and PXMD?
Innovation1 Biotech's Long-Term Debt of $0.56 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Diversified Financial Services company?
A good Long-Term Debt depends on the Diversified Financial Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Innovation1 Biotech's current Long-Term Debt is $0.56 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovation1 Biotech stock overvalued right now?
Innovation1 Biotech (IVBT) has a current Long-Term Debt of $0.56 Mil. The current Long-Term Debt is $0.56 Mil. Innovation1 Biotech's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Innovation1 Biotech (IVBT), the current Long-Term Debt is $0.56 Mil as of Feb. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovation1 Biotech Business Description

Address 7 Grand View Avenue, Somerville, MA, USA, 02143
Innovation1 Biotech Inc is a shell company.
12GF Score

Get the complete analysis for IVBT

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price